JW SHINYAK CORPORATION: debt-to-equity, ROE and more
KOSDAQ, Legal name JW SHINYAK CORPORATION
Latest figures are the FY2025 consolidated summary statements.
Latest fiscal year ratios (computed here)
- Debt/equity
- 43.0%
- Equity ratio
- 69.9%
- ROE
- 38.4%
- Op. margin
- 9.2%
- Rev. growth
- -12.9%
- Interest coverage
- n/a
Condition flags
- Operating profit for 5 straight years.
- Total equity is above paid-in capital. Not capital-impaired.
Interest coverage and dividends (OpenDART)
Interest expense and dividends come from DART's OpenDART annual-report filings, not the FSC summary statements used above. The source differs from the other tables on this page.
Interest coverage = operating profit ÷ interest expenseNo interest expense value yet for this company. Most companies fold interest expense into a single finance-costs line on their income statement, so it cannot be pulled out separately. Interest coverage is not computed here.
Dividends, last 3 fiscal years
No dividend data yet for this company.
Source values from the OpenDART (금융감독원 전자공시) annual report. Report fiscal year 2025.
Ratios by year (computed here)
Debt-to-equity = total liabilities ÷ total equity × 100Equity ratio = total equity ÷ total assets × 100ROE = net income ÷ year-end total equity × 100Operating margin = operating profit ÷ revenue × 100Revenue growth = (this year − last year) ÷ last year × 100
Computed from the source figures above with these formulas. Where the source's own debt-to-equity differs from ours, both are shown for that year.
| Fiscal year | Debt/equity | Equity ratio | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| FY2021 consolidated | 66.7% | 60.0% | 1.5% | 3.4% | n/a |
| FY2022 consolidated | 69.0% | 59.2% | 2.5% | 4.2% | 1.7% |
| FY2023 consolidated | 299.0% | 25.1% | -227.4% | 5.4% | 1.5% |
| FY2024 consolidated | 137.2% | 42.1% | 19.1% | 10.7% | -10.8% |
| FY2025 consolidated | 43.0% | 69.9% | 38.4% | 9.2% | -12.9% |
Source figures (FSC summary statements)
Amounts are the source values, shortened. A cell reported as zero may be blank in the source, so it is not used in any ratio.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | ₩101.0B | ₩102.7B | ₩104.2B | ₩93.0B | ₩81.0B |
| Operating profit | ₩3.4B | ₩4.3B | ₩5.6B | ₩10.0B | ₩7.5B |
| Pre-tax income | ₩2.6B | ₩3.0B | -₩35.6B | ₩5.9B | ₩14.0B |
| Net income | ₩837.2M | ₩1.4B | -₩37.4B | ₩5.1B | ₩15.7B |
| Total assets | ₩92.0B | ₩94.1B | ₩65.6B | ₩63.0B | ₩58.2B |
| Total liabilities | ₩36.8B | ₩38.4B | ₩49.2B | ₩36.5B | ₩17.5B |
| Total equity | ₩55.2B | ₩55.7B | ₩16.4B | ₩26.6B | ₩40.7B |
| Paid-in capital | ₩22.0B | ₩23.1B | ₩24.2B | ₩25.4B | ₩26.7B |
| Debt/equity (source value) | 66.7% | 69.0% | 299.0% | 137.2% | 43.0% |
Company outline (FSC)
- Market
- KOSDAQ
- Fiscal year end
- Dec
- Founded
- 1981-08-13
- Listed
- 03/02/11
- Employees
- 173
- Auditor
- 한영회계법인
- Audit opinion
- 적정의견
- Corporate reg. no.
- 1615110001291
- Outline updated
- 2026-09-24
Check the original filings
Read the annual report and audit report before you decide anything. The link opens a DART search for this company's name.
Search DART for JW신약Computed from the Financial Services Commission's company outline and summary statements (data.go.kr). Data as of 2026-09-24.